E. Duggan

1.6k citations
16 papers · 651 indexed · h-index 12
Topics
Extracellular vesicles in disease (6 papers)MicroRNA in disease regulation (4 papers)Gold and Silver Nanoparticles Synthesis and Applications (3 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

E. Duggan

16 papers receiving 637 citations

Peers

E. Duggan
Comparison fields: 5 of 95
  • Molecular Biology 516
  • Cancer Research 202
  • Biomedical Engineering 158
  • Immunology 61
  • Electronic, Optical and Magnetic Materials 59
Replace Aaron K. Neumann with:
Aaron K. Neumann United States
Benedetta Santini Italy
Els J. van der Vlist Netherlands
Nadim Tawil Canada
Tomoko Kawaguchi Japan
M. A. Livshits Russia
Renée S. Richards Australia
Frans Nauwelaers Germany
Lezlee Coghlan United States
Natalia Ortiz Costa Rica
E. Duggan relative to Aaron K. Neumann United States Aaron K. Neumann's profile →
Citations per field
00.5×9.8×
Aaron K. Neumann · 1×
Citations per year

Countries citing papers authored by E. Duggan

Since Specialization
Citations

This map shows the geographic impact of E. Duggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Duggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Duggan more than expected).

Fields of papers citing papers by E. Duggan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Duggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Duggan. The network helps show where E. Duggan may publish in the future.

Co-authorship network of co-authors of E. Duggan

This figure shows the co-authorship network connecting the top 25 collaborators of E. Duggan. A scholar is included among the top collaborators of E. Duggan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Duggan. E. Duggan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 8
2 56
3 21
4 8
5 32
6 90
7 107
8 11
9 156
10 12
11 1
12 13
13 67
14 32
15 36
16 1

About E. Duggan

E. Duggan is a scholar working on Cancer Research, Virology and Molecular Biology, having authored 16 papers that have together received 651 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (4 papers) and Gold and Silver Nanoparticles Synthesis and Applications (3 papers). The work is most often cited by research in Cancer Research (202 citations), Biophysics (45 citations) and Molecular Biology (516 citations). E. Duggan has collaborated with scholars based in United States, China and Japan. Frequent co-authors include John P. Nolan, Samuel A. Stoner, Abraham Guerrero, James R. Turk, Padma Kumar Narayanan, Clark C. Chen, Bob S. Carter, Johnny Akers, Fred H. Hochberg and Valya Ramakrishnan. Their work appears in journals such as PLoS ONE, Nature Cell Biology and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026